Lipomics

Sacramento, United States Founded: 2000 • Age: 26 yrs Acquired By Metabolon
Diagnostics for metabolic, cardiovascular, and inflammatory conditions are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Lipomics

Lipomics is a company based in Sacramento (United States) founded in 2000 was acquired by Metabolon in August 2012. Lipomics operates in a competitive market with competitors including SD Biosensor, GEN inCode, SpectraWAVE, Lepu Medical Technology and Diadexus, among others.

  • Headquarter Sacramento, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lipomics Technologies, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Metabolon

    & 1 more

  • Employee Count
    Not available
  • Acquired by
    Metabolon

    & 1 more

    (Aug 01, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lipomics

Premium access

Detailed funding history for Lipomics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Lipomics

Lipomics has secured backing from 2 investors. Prominent investors backing the company include Metabolon and Tethys BioScience.

All
Investor Description Founded Year Domain Location
Develops biological markers for medical diagnostic applications.
Locked Locked Locked
Solutions for biomarker discovery and diagnostic testing are provided.
Locked Locked Locked
Premium access

Investor details for Lipomics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lipomics

Investments
Premium access

Investment portfolio details for Lipomics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Lipomics

Premium access

Detailed financials for Lipomics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lipomics Comparisons

Lipomics Primary company
Description
Diagnostics for metabolic, cardiovascular, and inflammatory ...
Location
Sacramento, United States
Founded Year
2000
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Lipomics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lipomics

Lipomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, GEN inCode, SpectraWAVE, Lepu Medical Technology and Diadexus, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
Locked Locked Locked
Genetic and clinical data are integrated for precision cardiac medicines.
Locked Locked Locked
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
Locked Locked Locked
Interventional cardiology devices are developed and marketed globally.
Locked Locked Locked
Molecular diagnostic tests for cardiovascular disorders are developed and marketed.
Locked Locked Locked
3D holographic display solutions for medical imaging are provided.
Premium access

Detailed competitors of Lipomics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lipomics

Premium access

Complete news archive for Lipomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lipomics

Lipomics was founded in 2000.

Lipomics is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.

Lipomics was founded in 2000 in Sacramento, United States, and operated in the diagnostics sector for metabolic, cardiovascular, and inflammatory conditions. Proprietary TrueMass lipid profiling technology was utilized to offer metabolite profiling, biomarker discovery, and metabolism consultation services. Quantitative assays were applied to study disease metabolism, drug or food impacts, and biomarker identification for clinical trials and products. The company was acquired by Metabolon in August 2012.

Lipomics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.

Lipomics has 2 investors. Key investors include Metabolon, and Tethys BioScience.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available